Healthcare AI (HAIAF) OKs $0.10 monthly extension to 2026

Healthcare AI Acquisition Corp. (HAIAF) filed an 8-K/A to correct a scrivener error and report shareholder approval of an Extension Amendment Proposal.

Rhea-AI Filing Summary

Healthcare AI Acquisition Corp. (HAIAF) filed an 8-K/A to correct a scrivener error and report shareholder approval of an Extension Amendment Proposal. The change allows the company to extend its deadline to complete a business combination from October 14, 2025, on a month-to-month basis, up to October 14, 2026.

For each monthly extension, the company must deposit $0.10 per non-redeemed public share into its trust account. This structure preserves the SPAC’s optionality to continue pursuing a merger while compensating remaining public shareholders each month the timeline is extended.

Insights

SPAC governance analyst

Shareholders approved monthly extensions with a per-share cash deposit.

Healthcare AI Acquisition Corp. received approval to extend its business combination deadline month-to-month through October 14, 2026. Each extension requires a deposit of $0.10 for every non-redeemed public share into the trust account, aligning with common SPAC extension structures.

This mechanism provides time to finalize a merger while directly compensating remaining holders via trust contributions. Actual impact depends on how many months are used and the number of non-redeemed shares.

Key items hinge on future disclosures: the extent of monthly extensions taken and any announced target for a business combination.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did HAIAF shareholders approve in the 8-K/A?

They approved an Extension Amendment Proposal allowing month-to-month extensions of the business combination deadline up to October 14, 2026.

What is the monthly deposit requirement for HAIAF’s extension?

Each monthly extension requires a deposit of $0.10 per non-redeemed public share into the trust account.

From what date can HAIAF begin month-to-month extensions?

Extensions commence from October 14, 2025, and can continue month-to-month to October 14, 2026.

What is the purpose of the 8-K/A amendment for HAIAF?

It corrects a scrivener error and reports the shareholder vote results on the extension proposal.

How are HAIAF public shareholders affected by the extension?

Remaining public shareholders receive $0.10 per share into the trust account for each monthly extension.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/29/2025 - 03:57 PM Learn about SEC filing dates

0001848861true00018488612025-10-102025-10-100001848861haia:ClassAOrdinaryShareAndRedeemableWarrantMember2025-10-102025-10-100001848861haia:ClassAOrdinarySharesMember2025-10-102025-10-100001848861haia:ClassAOrdinaryShareWarrantMember2025-10-102025-10-10iso4217:USDxbrli:sharesiso4217:USDxbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K/A

 Amendment No. 1

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): October 29, 2025 (October 10, 2025)

HEALTHCARE AI ACQUISITION CORP.

(Exact name of registrant as specified in its charter)

Cayman Islands		001-41145		98-1585450
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

418 Broadway #6434

Albany NY 12207

(Address of principal executive offices, including zip code)

(917) 446-0469

Registrant’s telephone number, including area code: 

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

	☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
	☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
	☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
	☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Units, each consisting of one Class A Ordinary Share and one-half of one Redeemable Warrant		HAIUF		OTC Market Group, Inc,
Class A Ordinary Share, par value $0.0001 per share		HAIAF		OTC Market Group, Inc,
Warrant, each whole warrant exercisable for one Class A Ordinary Share for $11.50 per share		HAIWF		OTC Market Group, Inc,

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 

EXPLANATORY NOTE

This amendment to the Current Report on Form 8-K filed on October 14, 2025, by Healthcare AI Acquisition Corp. (the “Company”), is being filed to correct a scrivener error.

5.07 Submission of Matters to a Vote of Security Holders.

In connection with reporting the results of a shareholder meeting, the shareholders approved the proposal to amend the Company’s Articles of Association as a special resolution (“Extension Amendment Proposal”), giving the Company the right to extend the date by which it has to complete a business combination from October 14, 2025 on a month-to-month basis until October 14, 2026 by depositing into the trust account $0.10 per non-redeemed public share for each monthly extension deposited into the Company’s trust account.

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	HEALTHCARE AI ACQUISITION CORP.
Dated: October 29, 2025	By:	/s/ Jiande Chen
	Name:	Jiande Chen
	Title:	Chief Executive Officer

3